Usutani Hirotsugu, Yamamoto Kenji, Hashimoto Kazuki
Technology Research & Development Division, Process Research & Development Laboratories, Sumitomo Pharma Co., Ltd., Kasugade-naka 3-1-98, Konohana-ku, Osaka 554-0022, Japan.
ACS Omega. 2023 Mar 9;8(11):10373-10382. doi: 10.1021/acsomega.2c07997. eCollection 2023 Mar 21.
Microflow chemistry is one of the newest and most efficient technologies used today for the safe and effective production of medicines. In this paper, we show the use of this technology in the development of a manufacturing method for napabucasin, which has potential in the treatment of colorectal and pancreatic cancers. In conventional "batch-type" reactor systems, the generation of side products can be controlled with traditional techniques such as reagent reverse-addition and temperature control. However, there is a limitation to which the yield and purity can be improved by these methods, as both are constrained by the efficiency of heat/mass transfer. Applying microflow chemistry technology alters the parameters of the constraint through the use of precise mixing in a microchannel, which offers increased possibility for improving yields and process intensification of the napabucasin process. Reported herein is a proof-of-concept study for the scale-up production of napabucasin using microflow chemistry techniques for manufacturing at the kilogram scale.
微流控化学是当今用于安全有效地生产药品的最新且最有效的技术之一。在本文中,我们展示了该技术在开发一种用于萘布卡生的制造方法中的应用,萘布卡生在治疗结直肠癌和胰腺癌方面具有潜力。在传统的“间歇式”反应器系统中,可以通过诸如试剂反向添加和温度控制等传统技术来控制副产物的生成。然而,通过这些方法提高产率和纯度存在一定的局限性,因为两者都受到传热/传质效率的限制。应用微流控化学技术通过在微通道中进行精确混合来改变限制参数,这为提高萘布卡生产率和强化萘布卡生工艺提供了更大的可能性。本文报道了一项概念验证研究,该研究使用微流控化学技术在千克规模上进行萘布卡生的放大生产。